Revolutionary Cardiovascular
Health Monitoring

Simple and effective personal vascular health device for early identification of heart disease.



Lexington BioSciences (CSE: LNB) (OTC: LXGTF), introduces HeartSentry, a revolutionary, simple and effective technology for personalized measurement and monitoring of vascular health to detect the potential for cardiovascular disease at its earliest stages. The device is designed to measure the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke.

Read More


News Alert Signup

The Need

Heart Disease

Nearly 1 in 3 deaths in the USA are caused by heart disease and stroke.

Read More

The Solution

Early Detection

The only way to detect common vulnerability is to monitor endothelial function.

Read More

The Market

High Growth Self-Monitoring Sector

By 2020, $2.6 billion Global monitoring instruments market will increasingly shift to the high-growth home segment.

Read More

Our Team

Expert Leadership

Our team have successfully started, built and grown multiple life science companies.

Read More

Latest News